Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines

Study Identifier
MA-BTX-0806
CT.gov Identifier
NCT00856414
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Facial Aesthetics - Fillers
    • Study Drug
  • botulinum toxin Type A
    • Phase
    Phase 4
    Sex
    Female
    Age
    35 - 55 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Female subjects of any race, 35-55 years of age * Moderate to severe glabellar wrinkles (lines between the eyebrows)
    Exclusion Criteria:
    * Previous botulinum toxin therapy * Subjects who are pregnant, breast-feeding, or who are of childbearing potential and not practicing a reliable method of birth control * Subjects planning a facial cosmetic procedure or visible scars * Previous cosmetic surgery to the upper face * Medical condition that may increase their risk of exposure to botulinum toxin including diagnosed Myasthenia Gravis, Eaton-Lambert Syndrome, Amyotrophic Lateral Sclerosis, or any other disease that might interfere with neuromuscular function * History of facial nerve palsy * Allergy or sensitivity to any component of the study medication

    Protocol Summary

    This study evaluates the patient satisfaction and onset of effect following treatment with botulinum toxin Type A in the treatment of glabellar rhytids (frown lines)

    Study Locations

    Location
    Status
    Location
    West Palm Beach, Florida, United States
    Status
    Not applicable
    Location
    Livonia, Michigan, United States
    Status
    Not applicable